In addition to launching itself over stuff in its path, the bot has a step height of 22 cm (8.6 in) and can lock its wheels to climb over anything higher (well, up to 80 cm/31.5 in anyway). The ...

One of the best examples of this is parkour. Climbing buildings, jumping across rooftops and scaling skyscrapers might sound like the perfect way to live for select few people, but the remaining ...

Publisher Perp Games will release SUPERLOU-developed first-person parkour horror game Finding Frankie for PlayStation 5 and Xbox Series, the company announced. A release date was not announced.

But this time, its developer gave players a clear indication of how that extra time is being spent: improving parkour. And luckily for long-time fans, it sounds like the developers understand what ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...

Get Wall Street's Hottest Chart Every Morning RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients who ...

--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the ...

The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

We're kicking off the 43rd Annual Healthcare Conference this morning, and I couldn't be more delighted to introduce Vertex's CEO, Reshma Kewalramani. She's going to come on stage to give a ...